EP3319956
Setnar oxópýridínafleiður
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
5.7.2016EP published:
6.1.2021EP application number:
16734672.5
EP translation filed:
23.3.2021Grant published:
15.4.2021EPO information:
European Patent Register
Max expiry date:
4.7.2036Expiry date:
4.7.2026Next due date:
31.7.2026
Title:
SUBSTITUTED OXOPYRIDINE DERIVATIVES
Timeline
Today
5.7.2016EP application
6.1.2021EP Publication
23.3.2021Translation submitted
15.4.2021Registration published
4.7.2026Expires
Owner
Name:
Bayer Pharma AktiengesellschaftAddress:
Müllerstrasse 178, 13353 Berlin, DE
Inventor
Name:
JIMENEZ NUNEZ, EloisaAddress:
79104 Freiburg im Breisgau, DE
Name:
ACKERSTAFF, JensAddress:
40225 Düsseldorf, DE
Name:
RÖHRIG, SusanneAddress:
40724 Hilden, DE
Name:
HILLISCH, AlexanderAddress:
42651 Solingen, DE
Name:
MEIER, KatharinaAddress:
40822 Mettmann, DE
Name:
HEITMEIER, StefanAddress:
42489 Wülfrath, DE
Name:
TERSTEEGEN, AdrianAddress:
42111 Wuppertal, DE
Name:
STAMPFUSS, JanAddress:
40470 Düsseldorf, DE
Name:
ELLERBROCK, PascalAddress:
40215 Düsseldorf, DE
Name:
MEIBOM, DanielAddress:
42113 Wuppertal, DE
Name:
LANG, DieterAddress:
42553 Velbert, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
15176099Date:
9.7.2015Country:
EP
Number:
16157350Date:
25.2.2016Country:
EP
Classification
Categories:
C07D 401/14, C07D 413/14, C07D 401/10, C07D 413/10, A61K 31/4439, A61P 9/00, A61P 27/02
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 24.6.2021
Expires: 4.7.2022
Payer: Árnason Faktor ehf.
Number: 7
Paid: 29.6.2022
Expires: 4.7.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 28.6.2023
Expires: 4.7.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 24.6.2024
Expires: 4.7.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 7.7.2025
Expires: 4.7.2026
Payer: Árnason Faktor ehf.